Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;107:2011-2015
Published online before print April 7, 2003, doi: 10.1161/01.CIR.0000064900.76674.CC
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/15/2011    most recent
01.CIR.0000064900.76674.CCv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wasmund, S. L.
Right arrow Articles by Hamdan, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wasmund, S. L.
Right arrow Articles by Hamdan, M. H.
Related Collections
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2003;107:2011.)
© 2003 American Heart Association, Inc.


Clinical Investigation and Reports

Effect of Atrial Fibrillation and an Irregular Ventricular Response on Sympathetic Nerve Activity in Human Subjects

Stephen L. Wasmund, PhD; Jian-Ming Li, MD, PhD; Richard L. Page, MD; Jose A. Joglar, MD; Robert C. Kowal, MD, PhD; Michael L. Smith, PhD; Mohamed H. Hamdan, MD

From the University of Texas Southwestern Medical Center and Dallas Veterans Affairs Medical Center, Dallas, Tex.

Correspondence to Mohamed H. Hamdan, MD, Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Room C57.102, 5323 Harry Hines Blvd, Dallas, TX 75390-9047. E-mail Mohamed.Hamdan{at}utsouthwestern.edu


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background— Although the hemodynamic changes associated with atrial fibrillation (AF) have been extensively studied, the neural changes remain unclear. We hypothesized that AF is associated with an increase in sympathetic nerve activity (SNA) and that the irregular ventricular response contributes to this state of sympathoexcitation.

Methods and Results— In 8 patients referred for an electrophysiological study, SNA, blood pressure (BP), central venous pressure (CVP), and heart rate were recorded during 3 minutes of normal sinus rhythm (NSR) and 3 minutes of induced AF. In 5 of 8 patients who converted to NSR, right atrial (RA) pacing was performed for 3 minutes in atrial pacing triggered by ventricular sensing mode triggered by playback of an FM tape previously recorded from the right ventricle during AF (RA-irregular) and atrial pacing inhibited by atrial sensing mode at a rate equal to the mean heart rate obtained during AF (RA-regular). SNA data were expressed as percentage of baseline during NSR. SNA increased in all 8 patients during induced AF compared with NSR (171±40% versus 100%, respectively; P<0.01). This was associated with a trend for a decrease in BP and an increase in CVP (P=0.02). Similarly, SNA was significantly higher during RA-irregular pacing compared with RA-regular pacing (124±24% versus 91±20%, respectively; P=0.03). BP and CVP were not significantly different between the 2 pacing modes.

Conclusions— Induced AF results in a significant increase in SNA, which is in part attributable to the irregular ventricular response. Our findings suggest that restoring NSR or regularity might be beneficial, particularly in patients with heart failure.


Key Words: atrium • fibrillation • nervous system


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical practice.1 Most studies seem to suggest that AF is associated with increased mortality. This increase in mortality is thought to be attributable to the cardiovascular conditions associated with AF. However, a recent study from the Framingham cohort2 showed that AF per se was associated with a 1.5- to 1.9-fold increase in mortality risk, even after adjusting for the preexisting cardiovascular conditions associated with AF. Although the hemodynamic changes associated with AF have been extensively studied, the neural changes resulting from this arrhythmia remain unclear. An understanding of the effect of AF and in particular the effect of an irregular ventricular response on sympathetic activity may shed some light on the etiology behind the reduced survival in patients with AF. To our knowledge, such work has not been done.

The purpose of the present study was to determine the effect of induced AF on sympathetic nerve activity (SNA). We hypothesized that AF is associated with an increase in SNA and that the irregular ventricular response contributes to this state of sympathoexcitation.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Study Patients
The study was performed at the Dallas Veterans Affairs Medical Center and was approved by the local institutional review board. Informed consent was obtained from all patients, and all procedures were in accordance with institutional guidelines. All patients with a history of supraventricular tachycardia or paroxysmal atrial flutter referred for an electrophysiological study were screened. Patients who were not in normal sinus rhythm at the time of the study were excluded. A total of 10 patients were enrolled in the study. Successful nerve recordings were obtained in 8 patients. The data from these 8 patients form the material of this study.

Electrophysiological Studies
Patients were studied in the drug-free postabsorptive state after informed consent was obtained. Three quadripolar catheters were inserted percutaneously and positioned in the high lateral RA, RV apex, and across the tricuspid valve for His-bundle recording. Atrial and ventricular pacing thresholds were measured and pacing was performed at twice diastolic pacing threshold.

Measurements
Efferent, postganglionic muscle SNA was recorded from the left peroneal nerve, as previously described.3 Briefly, a sterile microelectrode was inserted into a fascicle of the peroneal nerve near the fibular head. The nerve signals were amplified, filtered (700 to 2000 Hz), rectified, and discriminated. Raw nerve signals were integrated (time constant, 0.01 seconds) to produce a mean voltage display for quantitative analysis. Muscle sympathetic nerve bursts during sinus rhythm were readily recognized by their tight temporal relationship to the sinus cardiac cycle, their increasing frequency during Valsalva maneuvers, the occurrence of large bursts accompanying premature ventricular beats, and the failure to respond to arousal stimuli or stroking of the skin in the region of innervation. The SNA was quantified as the total activity derived from the sum of the area of the SNA bursts for a given time period. Area was used for these analyses, because, compared with the burst amplitude, it more appropriately reflects the changes in SNA associated with the wide variations in arterial BP that can occur during AF. SNA data were expressed as a percentage of baseline burst area during normal sinus rhythm (NSR) before AF induction and RA pacing. Arterial blood pressure (BP) was directly recorded with a 5F catheter inserted into the right femoral artery. Central venous pressure (CVP) was continuously recorded with a catheter placed in the right atrium via the right femoral vein. Heart rate (HR) was derived from continuous ECG recording of at least 2 leads (typically leads II and V1).

Experimental Protocol
After obtaining acceptable recordings of SNA, BP, CVP, and HR, the following protocol was performed. Three minutes of data during NSR were recorded (NSR). AF was then induced with rapid atrial pacing or atrial premature stimulation, and 3 minutes of AF data were recorded (AF). During AF, the bipolar electrogram from the RV catheter was recorded onto a frequency-modulated (FM) tape using an analog data recorder for subsequent use (see below). After obtaining NSR and AF data, patients were monitored for 15 minutes. If AF persisted, they underwent electrical cardioversion, and no additional data were recorded in these patients. In those who had spontaneous cardioversion, right atrial (RA) pacing was performed for 3 minutes in an AVT mode triggered from the previous FM tape recordings (RA-irregular) and in an AAI mode at a rate equal to the mean HR obtained during AF (RA-regular). RA-irregular and RA-regular pacing were done at random with a 1-minute recovery time and 1-minute baseline in between.

In summary, patients who required electrical cardioversion had recordings during NSR and AF (n=8), and those who converted spontaneously had recordings during NSR, AF, RA-irregular, and RA-regular pacing (n=5). Data analysis in all patients was performed during the last minute of the 3-minute recordings.

Statistics
All data are presented as mean±SEM. All data sets were tested for normality using a Kolmogorov-Smirnov test. Group comparisons of NSR versus AF and RA-regular versus RA-irregular were performed with a paired t test. A signed-rank sum was used for comparisons in which normality failed. For all analyses, significance was set at an {alpha} level of 0.05.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Clinical Characteristics
All patients were men, with a mean age of 64±2 years. Four patients had the diagnosis of atrial flutter, 3 atrioventricular nodal tachycardia, and 1 atrial tachycardia. All patients were in NSR at the time of the electrophysiological study. The clinical characteristics of all subjects are summarized in the Table.


View this table:
[in this window]
[in a new window]
 
Patients’ Clinical Characteristics

Atrial Fibrillation Compared With Normal Sinus Rhythm
Atrial fibrillation was successfully induced in all 8 patients. Figure 1 is a representative tracing of SNA, BP, and CVP during NSR and AF in 1 subject. A summary of the hemodynamic and SNA changes associated with AF compared with NSR is provided in Figure 2. SNA was significantly higher during AF compared with NSR (171±40% versus 100%, respectively; P<0.01). The increase in SNA was associated with a trend for a decrease in BP, which was not statistically significant. On the other hand, a significant increase in CVP was noted during AF compared with NSR (13±1 versus 11±1 mm Hg, respectively; P=0.02).



View larger version (41K):
[in this window]
[in a new window]
 
Figure 1. SNA, BP, and CVP recordings from a subject during NSR and AF. SNA increased during AF compared with NSR. The increase in SNA was associated with a decrease in BP and an increase in CVP.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 2. Mean values for SNA, BP, and CVP during NSR and AF. SNA was significantly higher during AF compared with NSR. BP tended to be lower during AF; however, the difference was not significant. CVP was significantly higher during AF compared with NSR.

RA-Irregular Pacing Compared With RA-Regular Pacing
Regular and irregular RA pacing was performed in 5 of 8 patients who converted spontaneously to NSR. In the remaining 3 patients, electrical cardioversion was required. In these patients, no additional data were acquired because of the drugs used during anesthesia. Figure 3 illustrates a sample tracing of SNA, BP, and CVP during RA-regular and RA-irregular pacing in 1 subject. A summary of the hemodynamic and SNA changes associated with RA-regular and RA-irregular pacing is provided in Figure 4. SNA was significantly higher during RA-irregular pacing compared with RA-regular pacing (124±24% versus 91±20%, respectively; P=0.03). BP and CVP were not significantly different between the 2 pacing modes.



View larger version (48K):
[in this window]
[in a new window]
 
Figure 3. SNA, BP, and CVP recordings from a subject during regular RA pacing (RA-regular) and irregular RA pacing (RA-irregular). SNA increased during RA-irregular pacing compared with RA-regular. No significant changes in BP or CVP were noted.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 4. Mean values for SNA, BP, and CVP during regular RA pacing (RA-regular) and irregular RA pacing (RA-irregular). SNA was significantly higher during RA-irregular pacing compared with RA-regular pacing. BP and CVP were not statistically significant.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
The main findings from this study are that induced AF results in a significant increase in sympathetic activity compared with normal sinus rhythm and an irregular ventricular response is associated with a higher sympathetic activity compared with a regular ventricular response. To our knowledge, this is the first study to assess the effect of AF and irregularity on sympathetic activity in human subjects.

Effect of AF on Morbidity/Mortality
Carson et al4 analyzed, retrospectively, the data from the Veterans administration Heart Failure Trial (V-HeFT) studies and found no difference in mortality in patients with AF compared with NSR. On the other hand, in the largest study to date combining data from the Studies Of Left Ventricular Dysfunction (SOLVD) trials, Dries et al5 found AF to be associated with an increased risk for all-cause mortality in patients with mild to moderate CHF. Similarly, a recent study from the Framingham cohort2 showed that AF was associated with a 1.5- to 1.9-fold increase in mortality even after adjusting for the preexisting cardiovascular conditions with which AF was associated. The mechanism for this increased mortality independent of other risk factors is unknown. A possible explanation could be the autonomic changes that accompany AF.

We have previously shown that arterial baroreflexes play a major role in mediating sympathoexcitation during supraventricular and ventricular tachycardias.6–8 In the present study, we found that SNA was increased during AF with a trend for a decrease in BP, suggesting again a primary role of the arterial baroreflexes. In addition, we found that irregular pacing was associated with an increase in sympathetic activity compared with regular pacing, suggesting that the irregular ventricular response during AF may play a role in mediating sympathoexcitation. The relative role of the arterial and cardiopulmonary baroreflex gain and other potential mechanisms of sympathoexcitation in the control of SNA during AF remains unclear.

The Detrimental Effects of an Irregular Ventricular Response
The detrimental effects of an irregular ventricular response have been highlighted in several elegant studies.9–11 Clark et al9 assessed the hemodynamic effects of an irregular ventricular cycle length in 16 patients with AF referred for atrioventricular junctional ablation. Compared with an irregular sequence of RR intervals, VVI pacing at the same average rate as AF resulted in a significant increase in cardiac output and a significant decrease in pulmonary capillary wedge pressure and right atrial pressure. A limitation of that study was that comparison was made between intrinsically conducted beats (AF) and RV paced beats. Nevertheless, this study clearly showed that a regular ventricular response resulted in better hemodynamics compared with the irregularity seen during AF. The importance of a regular ventricular response is additionally evidenced by the results of a study by Kubac et al12 that showed improvement in left ventricular function after cardioversion, even in patients with a previously well-controlled ventricular rate. Therefore, most studies seem to suggest that the hemodynamic changes associated with an irregular ventricular response are detrimental. To our knowledge, the neural changes associated with an irregular ventricular response have not been assessed.

In the present study, we found that an irregular ventricular response was associated with a higher sympathetic activity compared with a regular ventricular response. Our findings complement the results of the previously mentioned studies. Therefore, the relationship between AF and congestive heart failure seems to be even more intriguing than previously thought. In addition to tachycardia-induced cardiomyopathy,13,14 AF could theoretically lead to impairment in left ventricular function as a result of the irregular ventricular response. This hypothesis, however, remains to be proven.

Clinical Implications
Elevated levels of sympathetic activity have long been shown to be detrimental, particularly in patients with left ventricular dysfunction. Our findings of increased sympathetic activity during AF suggest that restoring sinus rhythm might be beneficial in patients with paroxysmal or persistent AF. On the other hand, the increase in SNA during irregular pacing compared with regular pacing suggests that in addition to rate control, restoring regularity might be important in patients with permanent AF. The relative role of rate and irregularity in mediating sympathoexcitation at different rates and the long-term effects of restoring a regular ventricular response in patients with clinical AF remain to be seen.

Study Limitations
This study has limitations. First, our findings may not apply to patients with clinical AF. Patients with clinical AF may have impairment of the cardiopulmonary baroreflex gain, and, as such, the neural changes in these patients might be different. However, we believe our findings are likely to be true in these patients, because impairment of the cardiopulmonary baroreflex gain should result in less sympathoinhibition and thus even a greater elevation of SNA during AF. Second, we did not assess the effect of AF and an irregular ventricular response on SNA at different rates. Therefore, our findings of a higher SNA during AF compared with NSR may not be true at faster or slower rates. Close analysis of the data, however, suggests that the increase in SNA was primarily attributable to the irregularity and not the tachycardia rate. Indeed, RA-regular pacing at a rate equal to the AF rate (112±8 bpm) resulted in a decrease in SNA compared with baseline (91±20% of baseline). This finding suggests that the increase in HR associated with AF in this study did not play a major role in mediating the sympathoexcitation associated with AF. We predict that the detrimental effect of irregularity is likely to decrease as the ventricular rate increases. The relative role of rate and irregularity on the hemodynamic and neural changes remains to be evaluated. Finally, the number of subjects we studied is small. Although a larger number of patients might have yielded different results, we think this is unlikely, because every patient (8 of 8) had an increase in SNA during AF compared with NSR.

Conclusion
In summary, we have shown for the first time that AF is associated with an increase in sympathetic activity and that an irregular ventricular response is associated with a higher sympathetic activity compared with a regular ventricular response. Therefore, our findings may help explain why AF, and in particular an irregular ventricular response, is detrimental in patients with congestive heart failure. The effect of restoring sinus rhythm and a regular ventricular response on sympathetic activity in patients with clinical AF remains to be determined.


*    Acknowledgments
 
This work has been supported by a National Institutes of Health grant (R01 HL-65490-01) to Dr Hamdan.

Received December 17, 2002; revision received January 31, 2003; accepted February 4, 2003.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Feinberg WM, Blackshear JL, Laupacis A, et al. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med. 1995; 155: 469–473.[Abstract/Free Full Text]

2. Benjamin EJ, Wolf PA, D’Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998; 98: 946–952.[Abstract/Free Full Text]

3. Wallin BG, Eckberg DL. Sympathetic transients caused by abrupt alterations of carotid baroreceptor activity in humans. Am J Physiol. 1982; 242: H185–H190.[Medline] [Order article via Infotrieve]

4. Carson PE, Johnson GR, Dunkman WB, et al. The influence of atrial fibrillation on prognosis in mild to moderate heart failure: the V-He FT VA Cooperative Studies Group. Circulation. 1993; 87: VI102–VI110.[Medline] [Order article via Infotrieve]

5. Dries DL, Exner DV, Gersh BJ, et al. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 1998; 32: 695–703.[Abstract/Free Full Text]

6. Smith ML, Joglar JA, Wasmund SL, et al. Reflex control of sympathetic activity during simulated ventricular tachycardia in humans. Circulation. 1999; 100: 628–634.[Abstract/Free Full Text]

7. Hamdan MH, Joglar JA, Page RL, et al. Baroreflex gain predicts blood pressure recovery during simulated ventricular tachycardia in humans. Circulation. 1999; 100: 381–386.[Abstract/Free Full Text]

8. Hamdan MH, Zagrodzky JD, Page RL, et al. Effect of P-wave timing during supraventricular tachycardia on the hemodynamic and sympathetic neural response. Circulation. 2001; 103: 96–101.[Abstract/Free Full Text]

9. Clark DM, Plumb VJ, Epstein AE, et al. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol. 1997; 30: 1039–1045.[Abstract]

10. Daoud EG, Weiss R, Bahu M, et al. Effect of an irregular ventricular rhythm on cardiac output. Am J Cardiol. 1996; 78: 1433–1436.[CrossRef][Medline] [Order article via Infotrieve]

11. Naito M, David D, Michelson EL, et al. The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model. Am Heart J. 1983; 106: 284–291.[CrossRef][Medline] [Order article via Infotrieve]

12. Kubac G, Malowany L. Functional capacity of patients with atrial fibrillation and controlled heart rate before and after cardioversion. Can J Cardiol. 1992; 8: 941–946.[Medline] [Order article via Infotrieve]

13. Grogan M, Smith HC, Gersh BJ, et al. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol. 1992; 69: 1570–1573.[CrossRef][Medline] [Order article via Infotrieve]

14. Fenelon G, Wijns W, Andries E, et al. Tachycardiomyopathy: mechanisms and clinical implications. Pacing Clin Electrophysiol. 1996; 19: 95–106.[CrossRef][Medline] [Order article via Infotrieve]




This article has been cited by other articles:


Home page
Mayo Clin Proc.Home page
M. A. Crandall, D. J. Bradley, D. L. Packer, and S. J. Asirvatham
Contemporary Management of Atrial Fibrillation: Update on Anticoagulation and Invasive Management Strategies
Mayo Clin. Proc., July 1, 2009; 84(7): 643 - 662.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
F. T. Range, M. Paul, K. P. Schafers, T. Acil, P. Kies, S. Hermann, O. Schober, G. Breithardt, T. Wichter, and M. A. Schafers
Myocardial Perfusion in Nonischemic Dilated Cardiomyopathy With and Without Atrial Fibrillation
J. Nucl. Med., March 1, 2009; 50(3): 390 - 396.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
F. T. Range, M. Schafers, T. Acil, K. P. Schafers, P. Kies, M. Paul, S. Hermann, B. Brisse, G. Breithardt, O. Schober, et al.
Impaired myocardial perfusion and perfusion reserve associated with increased coronary resistance in persistent idiopathic atrial fibrillation
Eur. Heart J., September 2, 2007; 28(18): 2223 - 2230.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Guazzi, M. Berti, S. Belletti, G. Reina, and M. D. Guazzi
Exercise metaboreflex activation and endothelial function impairment in atrial fibrillation
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2396 - H2402.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Guazzi, S. Belletti, E. Bianco, L. Lenatti, and M. D. Guazzi
Endothelial dysfunction and exercise performance in lone atrial fibrillation or associated with hypertension or diabetes: different results with cardioversion
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H921 - H928.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
G. V. Naccarelli
Antiadrenergic Therapy in the Control of Atrial Fibrillation
Journal of Cardiovascular Pharmacology and Therapeutics, October 1, 2005; 10(4_suppl): S33 - S43.
[Abstract] [PDF]


Home page
Am J Crit CareHome page
L. G. Futterman and L. Lemberg
Atrial Fibrillation
Am. J. Crit. Care., September 1, 2005; 14(5): 438 - 440.
[Full Text] [PDF]


Home page
CirculationHome page
R. H. Falk
Rate Control Is Preferable to Rhythm Control in the Majority of Patients With Atrial Fibrillation
Circulation, June 14, 2005; 111(23): 3141 - 3150.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Guazzi, S. Belletti, G. Tumminello, C. Fiorentini, and M. D. Guazzi
Exercise hyperventilation, dyspnea sensation, and ergoreflex activation in lone atrial fibrillation
Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2899 - H2905.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y.-M. Cha, M. M. Redfield, W.-K. Shen, and B. J. Gersh
Atrial Fibrillation and Ventricular Dysfunction: A Vicious Electromechanical Cycle
Circulation, June 15, 2004; 109(23): 2839 - 2843.
[Full Text] [PDF]


Home page
Eur Heart JHome page
P. A Gould, M. D Esler, and D. M Kaye
Chronic atrial fibrillation does not influence the magnitude of sympathetic overactivity in patients with heart failure
Eur. Heart J., September 2, 2003; 24(18): 1657 - 1662.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/15/2011    most recent
01.CIR.0000064900.76674.CCv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wasmund, S. L.
Right arrow Articles by Hamdan, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wasmund, S. L.
Right arrow Articles by Hamdan, M. H.
Related Collections
Right arrow Arrhythmias, clinical electrophysiology, drugs